All of the following drugs can be used for intestinal ameobiasis except :
**Question:** All of the following drugs can be used for intestinal ameobiasis except:
A. Metronidazole
B. Tinidazole
C. Nitrofurantoin
D. Chloroquine
**Core Concept:**
Amebiasis is a parasitic infection caused by the protozoan Entamoeba histolytica. The infection primarily affects the large intestine and liver, leading to symptoms such as abdominal pain, diarrhea, and fever. Treatment options for intestinal amebiasis include antiparasitic drugs targeting the parasite's survival and reproduction.
**Why the Correct Answer is Right:**
The correct answer, **D. Chloroquine**, is not used for the treatment of intestinal amebiasis because it is primarily an antimalarial drug. Chloroquine works by inhibiting the growth and development of Plasmodium falciparum, a parasite responsible for causing malaria. It does not target Entamoeba histolytica, the causative agent of amebiasis.
**Why Each Wrong Option is Incorrect:**
A. Metronidazole (Correct Answer) and Tinidazole are both nitroimidazole derivatives that target anaerobic bacteria and protozoa, including Entamoeba histolytica. These drugs are effective in eradicating the parasite and alleviating the symptoms of amebiasis.
B. Nitrofurantoin is primarily used for the treatment of urinary tract infections caused by bacteria, particularly Escherichia coli and Klebsiella pneumoniae. It does not target Entamoeba histolytica and is therefore incorrect for amebiasis treatment.
**Clinical Pearl:**
In the management of intestinal amebiasis, the recommended first-line drugs are metronidazole and tinidazole due to their effectiveness against Entamoeba histolytica. Chloroquine, Nitrofurantoin, and other antimalarial drugs are not suitable for treating amebiasis, as they target different pathogens or are not effective against protozoa. It is essential for medical professionals to select the appropriate drug based on the correct understanding of the disease and the pathogens involved. This ensures optimal treatment outcomes and minimizes the risk of drug resistance and potential side effects.